Literature DB >> 22736767

Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype.

Juan J Calix1, Richard J Porambo, Allison M Brady, Thomas R Larson, Janet Yother, Chitrananda Abeygunwardana, Moon H Nahm.   

Abstract

The bacterial pathogen Streptococcus pneumoniae expresses one of over 90 structurally distinct polysaccharide (PS) capsule serotypes. Prior PS structural analyses of the vaccine-associated serotype 20 do not agree with reports describing the genes that mediate capsule synthesis. Furthermore, using immunized human sera-based assays, serological differences were recently noted among strains typed as serotype 20. We examined the capsule structures of two serologically dissimilar serotype 20 strains, 20α and 20β, by extensive biochemical analysis. 20α PS was composed of the previously described serotype 20 hexasaccharide repeat unit, whereas the 20β PS was composed of a novel heptasaccharide repeat unit containing an extra branching α-glucose residue. Genetic analysis of the subtypes revealed that 20α may have arisen from a 20β progenitor following loss of function mutation to the glycosyltransferase gene whaF. Conventional serotyping methods using rabbit polyclonal or mouse monoclonal antibodies were unable to distinguish the subtypes. However, genetic analysis of multiple "serotype 20" clinical isolates revealed that all strains contain the 20β genotype. We propose naming bacteria that express the previously described 20α capsule structure 20A and bacteria that express the novel 20β capsule structure 20B, a new pneumococcal serotype.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22736767      PMCID: PMC3431705          DOI: 10.1074/jbc.M112.380451

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Evolutionary genetics of the capsular locus of serogroup 6 pneumococci.

Authors:  Angeliki Mavroidi; Daniel Godoy; David M Aanensen; D Ashley Robinson; Susan K Hollingshead; Brian G Spratt
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

2.  Full assignment of the 1H and 13C spectra and revision of the O-acetylation site of the capsular polysaccharide of Streptococcus pneumoniae Type 33F, a component of the current pneumococcal polysaccharide vaccine.

Authors:  Xavier Lemercinier; Christopher Jones
Journal:  Carbohydr Res       Date:  2005-11-17       Impact factor: 2.104

3.  Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar).

Authors:  Daniel J Isaacman; Mark A Fletcher; Bernard Fritzell; Vincent Ciuryla; Jennifer Schranz
Journal:  Vaccine       Date:  2006-09-18       Impact factor: 3.641

4.  Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

Authors:  Susan S Huang; Richard Platt; Sheryl L Rifas-Shiman; Stephen I Pelton; Donald Goldmann; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

5.  Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies.

Authors:  Jigui Yu; Jisheng Lin; William H Benjamin; Ken B Waites; Che-hung Lee; Moon H Nahm
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

6.  Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae.

Authors:  In Ho Park; David G Pritchard; Rob Cartee; Angela Brandao; Maria Cristina C Brandileone; Moon H Nahm
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

7.  Predicted functions and linkage specificities of the products of the Streptococcus pneumoniae capsular biosynthetic loci.

Authors:  David M Aanensen; Angeliki Mavroidi; Stephen D Bentley; Peter R Reeves; Brian G Spratt
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

8.  Differential effects of pneumococcal vaccines against serotypes 6A and 6C.

Authors:  In H Park; Matthew R Moore; John J Treanor; Stephen I Pelton; Tamara Pilishvili; Bernard Beall; Mark A Shelly; Barbara E Mahon; Moon H Nahm
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

9.  Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children.

Authors:  Karen L Sleeman; David Griffiths; Fiona Shackley; Linda Diggle; Sunetra Gupta; Martin C Maiden; E Richard Moxon; Derrick W Crook; Timothy E A Peto
Journal:  J Infect Dis       Date:  2006-07-25       Impact factor: 5.226

10.  Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes.

Authors:  Stephen D Bentley; David M Aanensen; Angeliki Mavroidi; David Saunders; Ester Rabbinowitsch; Matthew Collins; Kathy Donohoe; David Harris; Lee Murphy; Michael A Quail; Gabby Samuel; Ian C Skovsted; Margit Staum Kaltoft; Bart Barrell; Peter R Reeves; Julian Parkhill; Brian G Spratt
Journal:  PLoS Genet       Date:  2006-03-10       Impact factor: 5.917

View more
  81 in total

1.  Streptococcus pneumoniae phosphotyrosine phosphatase CpsB and alterations in capsule production resulting from changes in oxygen availability.

Authors:  K Aaron Geno; Jocelyn R Hauser; Kanupriya Gupta; Janet Yother
Journal:  J Bacteriol       Date:  2014-03-21       Impact factor: 3.490

2.  Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.

Authors:  Allison M Brady; Juan J Calix; Jigui Yu; Kimball Aaron Geno; Gary R Cutter; Moon H Nahm
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

3.  Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization.

Authors:  Lance E Keller; Xiao Luo; Justin A Thornton; Keun-Seok Seo; Bo Youn Moon; D Ashley Robinson; Larry S McDaniel
Journal:  Clin Vaccine Immunol       Date:  2015-08-26

4.  Prevalence of nasopharyngeal carriage of Streptococcus pneumoniae in children 7 to 14 years in 2016: A survey before pneumococcal conjugate vaccine introduction in Iran.

Authors:  Manoochehr Karami; Seyed Mehdi Hosseini; Seyyed Hamid Hashemi; Sima Ghiasvand; Omid Zarei; Nasim Safari; Hossein Erfani; Mohammad Yousef Alikhani
Journal:  Hum Vaccin Immunother       Date:  2019-07-24       Impact factor: 3.452

5.  Blood collection tubes influence serum ficolin-1 and ficolin-2 levels.

Authors:  Allison M Brady; Brady L Spencer; Ann R Falsey; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

6.  Challenges of using molecular serotyping for surveillance of pneumococcal disease.

Authors:  Victoria Magomani; Nicole Wolter; Stefano Tempia; Mignon du Plessis; Linda de Gouveia; Anne von Gottberg
Journal:  J Clin Microbiol       Date:  2014-06-23       Impact factor: 5.948

7.  Position of O-Acetylation within the Capsular Repeat Unit Impacts the Biological Properties of Pneumococcal Serotypes 33A and 33F.

Authors:  Brady L Spencer; Jamil S Saad; Anukul T Shenoy; Carlos J Orihuela; Moon H Nahm
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

8.  Genetic diversity of fluoroquinolone-nonsusceptible Streptococcus pneumoniae clinical isolates and the first identification of serotype 20B in China.

Authors:  Q Guo; C Zhuo; Y Xu; W Huang; C Wang; S Zhang; J Huang; F Hu; D Zhu; F Yang; M Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-04       Impact factor: 3.267

9.  Biochemical activities of Streptococcus pneumoniae serotype 2 capsular glycosyltransferases and significance of suppressor mutations affecting the initiating glycosyltransferase Cps2E.

Authors:  David B A James; Kanupriya Gupta; Jocelyn R Hauser; Janet Yother
Journal:  J Bacteriol       Date:  2013-10-04       Impact factor: 3.490

Review 10.  Novel pneumococcal serotypes 6C and 6D: anomaly or harbinger.

Authors:  M Catherine McEllistrem; Moon H Nahm
Journal:  Clin Infect Dis       Date:  2012-08-16       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.